← Eichor
Study identifier: NCT05591040 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia

Condition: Dysphagia · Rehabilitation · Stroke  ·  Sponsor: IRCCS San Camillo, Venezia, Italy

PhaseNA
Planned participants100
Who can joinAll sexes, 18 Years to 89 Years
Healthy volunteersNo

About this study

The aim of the study is to evaluate whether the effect of biofeedback treatment is more effective than a control treatment in the recovery of dysphagia. This study will be a multicentric randomized, single-blind controlled study. The investigators intend to recruit 100 patients who have suffered a stroke and have dysphagia. Fifty patients will undergo training with bio-feedback (experimental group) and the other fifty patients will undergo standard training, using only verbal feedback rather than visual feedback (control group). Our hypothesis, based on the results obtained in some previous studies, is that in the control group the efficacy of the treatment will be lower in the absence of immediate visual feedback of strength, timing, coordination and efficacy of the swallowing act.

This description comes directly from the study's public registry record.

Talk to the study team

Sara Nordio  ·  3494990310  ·  snordio944@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Sara NordioVenice-Lido, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05591040